Novartis has acquired Selexys Pharmaceuticals, an Oklahoma City based company specializing in hematologic and inflammatory disorders, in a deal worth in $655

Novartis acquires Selexys Pharmaceuticals in $665m deal

Pharmaceutical Business Review-5 hours ago

Novartis has acquired Selexys Pharmaceuticals, an Oklahoma City based company specializing in hematologic and inflammatory disorders, in a deal worth ...

Novartis Acquires Selexys Pharmaceuticals
Investing News Network (press release) (registration) (blog)-Nov 21, 2016

Novartis Buys Sickle Cell Disease Startup for Up to $665M
Drug Discovery & Development-17 hours ago

View all